Agenus Stock Explodes: The Strategic Pivot That Could Redefine Colon Cancer Treatment
Agenus (AGEN) recorded its best single-day stock performance ever after announcing a radical strategic shift: scrapping a Phase 3 colorectal cancer study to focus on...
